Clinical Trial Update: TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ticagrelor versus clopidogrel in patients with acute coronary syndrome and severe or terminal chronic kidney disease undergoing percuta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED